RFA
Reilly Financial Advisors Portfolio holdings
AUM
$1.35B
This Quarter Return
+1.31%
1 Year Return
+22.56%
3 Year Return
+99.86%
5 Year Return
+130.24%
10 Year Return
–
AUM
$545M
AUM Growth
+$545M
(+19%)
Cap. Flow
+$88M
Cap. Flow
% of AUM
16.15%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
1,374
New
220
Increased
132
Reduced
106
Closed
374
Top Buys
| 1 |
Exxon Mobil
XOM
|
$14.7M |
| 2 |
RTX Corp
RTX
|
$10.7M |
| 3 |
Pfizer
PFE
|
$10.6M |
| 4 |
Chubb
CB
|
$10.4M |
| 5 |
DuPont de Nemours
DD
|
$9.99M |
Top Sells
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
$11.6M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$9.14M |
| 3 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
$8.01M |
| 4 |
UBS Group
UBS
|
$5.63M |
| 5 |
WFC.PRP
WELLS FARGO & COMPANY SER P
WFC.PRP
|
$858K |
Sector Composition
| 1 | Healthcare | 14.87% |
| 2 | Technology | 13.68% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Energy | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exxon Mobil
XOM
$487B
| $14.7M | 2.7% | +156,707 | New | +$14.7M |
|
2
TJX Companies
TJX
$152B
| $13.3M | 2.44% | 172,422 -617 | -0.4% | -$47.7K |
|
3
Berkshire Hathaway Class B
BRK.B
$1.09T
| $13M | 2.39% | 90,002 +907 | +1% | +$131K |
|
4
Apple
AAPL
$3.45T
| $12.8M | 2.34% | 133,508 +601 | +0.5% | +$57.5K |
|
5
Verizon
VZ
$186B
| $12.7M | 2.33% | 227,233 +2,273 | +1% | +$127K |
|
6
PepsiCo
PEP
$204B
| $12.3M | 2.25% | 115,982 +319 | +0.3% | +$33.8K |
|
|
AET
7
DELISTED
Aetna Inc
AET
| $12.2M | 2.25% | 100,192 -468 | -0.5% | -$57.2K |
|
8
NextEra Energy, Inc.
NEE
$148B
| $12.1M | 2.22% | 92,737 -6,371 | -6% | -$831K |
|
9
Comcast
CMCSA
$125B
| $11.3M | 2.08% | 173,955 -1,125 | -0.6% | -$73.3K |
|
10
Union Pacific
UNP
$133B
| $11.3M | 2.07% | 129,156 +4,378 | +4% | +$382K |
|
11
Schlumberger
SLB
$55B
| $11M | 2.01% | 138,812 +93,230 | +205% | +$7.37M |
|
|
12
RTX Corp
RTX
$212B
| $10.7M | 1.97% | +104,506 | New | +$10.7M |
|
13
Nike
NKE
$114B
| $10.6M | 1.95% | 192,142 +11,526 | +6% | +$636K |
|
|
14
Pfizer
PFE
$141B
| $10.6M | 1.95% | +301,159 | New | +$10.6M |
|
15
Mastercard
MA
$538B
| $10.6M | 1.94% | 120,141 +442 | +0.4% | +$38.9K |
|
16
Accenture
ACN
$162B
| $10.5M | 1.93% | 92,848 -3,439 | -4% | -$390K |
|
17
Alphabet (Google) Class C
GOOG
$2.58T
| $10.4M | 1.91% | 15,053 +496 | +3% | +$343K |
|
|
18
Chubb
CB
$110B
| $10.4M | 1.91% | +79,469 | New | +$10.4M |
|
19
CVS Health
CVS
$92.8B
| $10.4M | 1.9% | 108,229 +905 | +0.8% | +$86.6K |
|
20
Abbott
ABT
$231B
| $10M | 1.84% | 255,621 +253,051 | +9,846% | +$9.95M |
|
|
21
DuPont de Nemours
DD
$32.2B
| $9.99M | 1.83% | +200,950 | New | +$9.99M |
|
22
Gilead Sciences
GILD
$140B
| $9.89M | 1.82% | 118,579 +15,278 | +15% | +$1.27M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $9.78M | 1.79% | 42,322 +6,520 | +18% | +$1.51M |
|
24
TotalEnergies
TTE
$137B
| $9.47M | 1.74% | 196,842 +8,355 | +4% | +$402K |
|
25
Novo Nordisk
NVO
$251B
| $9.44M | 1.73% | 175,607 +8,957 | +5% | +$482K |
|